Herbs (Global Traditional) · European
Cowslip (Primula veris) (Primula veris)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Cowslip (Primula veris) contains triterpene saponins that support respiratory health by promoting mucus secretion and expectoration. The herb's flavonoid compounds including quercetin and isorhamnetin glycosides provide antioxidant and anti-inflammatory effects.
Cowslip (Primula veris) is a perennial herbaceous plant native to Europe and temperate Asia, belonging to the Primulaceae family. The flowers and roots are traditionally harvested and processed using aqueous or ethanolic extraction methods to isolate bioactive compounds including triterpene saponins, flavonoids, and phenolic glycosides.
No human clinical trials, randomized controlled trials (RCTs), or meta-analyses for Primula veris were identified in the research dossier. All reported pharmacological activities including secretolytic, expectorant, anti-inflammatory, and antioxidant effects are based solely on in vitro studies or compositional analyses rather than human trials.
No clinically studied dosage ranges are available as human trials are absent. Traditional preparations utilize flowers containing approximately 3% flavonoids and roots rich in saponins, but specific standardization protocols or therapeutic doses have not been established through clinical research. Consult a healthcare provider before starting any new supplement.
Cowslip (Primula veris) contains a diverse range of bioactive compounds with limited quantitative macronutrient data available for the whole plant. Flowers and leaves are the primary parts used. Key bioactive constituents include: Triterpene saponins (primulasaponin I and II, primulagenin A) concentrated in the root at approximately 5-10% dry weight, with flowers containing lower concentrations (~0.5-2% dry weight). Flavonoids are prominent in aerial parts, with quercetin glycosides (quercetin-3-glucoside, quercetin-3-rutinoside) and isorhamnetin glycosides estimated at 1-3% dry weight in flowers; kaempferol derivatives also present. Phenolic acids include chlorogenic acid and caffeic acid derivatives at trace to moderate levels (~0.1-0.5% dry weight). Vitamin C (ascorbic acid) is present in leaves at approximately 150-200 mg per 100g fresh weight, making young leaves a historically notable vitamin C source. Carotenoids including beta-carotene are present in flowers contributing to yellow pigmentation, estimated at 0.5-2 mg per 100g fresh weight. Mineral content includes potassium, calcium, and magnesium at modest levels typical of herbaceous plants; precise quantification is limited in the literature. Fiber content is present in leaves but not precisely documented. Essential oils are present in trace amounts (<0.1% dry weight). Bioavailability note: Saponin glycosides require intestinal hydrolysis for absorption; flavonoid bioavailability is moderate and dependent on gut microbiota activity for deglycosylation. Macronutrient data (carbohydrates, protein, fat) for edible portions is not formally documented in nutritional databases.
Cowslip's triterpene saponins enhance mucus production and facilitate expectoration by stimulating bronchial secretions and reducing mucus viscosity. The flavonoid compounds quercetin and isorhamnetin glycosides scavenge free radicals and inhibit inflammatory mediators including cyclooxygenase and lipoxygenase enzymes. These mechanisms support respiratory tract clearance and reduce oxidative stress in lung tissues.
Clinical evidence for cowslip is limited, with most research consisting of in vitro studies and compositional analyses rather than human trials. Traditional use and animal studies suggest respiratory benefits, but no controlled human trials have validated effectiveness for mucus clearance or cough relief. The antioxidant activity has been demonstrated only in laboratory settings using isolated compounds. Current evidence is insufficient to establish therapeutic dosing or clinical efficacy in humans.
Cowslip is generally considered safe when used traditionally, but comprehensive safety data is lacking. Potential allergic reactions may occur in individuals sensitive to plants in the Primulaceae family. No documented drug interactions exist, though theoretical interactions with expectorant medications could occur due to additive effects. Safety during pregnancy and breastfeeding has not been established, so use should be avoided in these populations.
